Global Cardiovascular Prosthetic Device Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • ID: 4420975
  • Report
  • Region: Global
  • 190 Pages
  • Occams Business Research and Consulting
1 of 4
The Global Cardiovascular Prosthetic Devices Market is Expected to Rise at a CAGR of 8.5%

FEATURED COMPANIES

  • Elixir Medical (U.S.)
  • Inspiremd (Israel)
  • Medtronic Plc. (U.S.)
  • Sorin Group (Italy)
  • Symetis Sa, (Switzerland)
  • MORE

The global cardiovascular prosthetic devices market is expected to rise at a CAGR of 8.5% during the forecast period 2016-2023. The key factors driving the market growth are rising prevalence of cardiovascular diseases, increasing geriatric population base, rising health insurance coverage, rising preference for minimally-invasive procedures and increasing prevalence of valvular disease and atrial septal defect (ASD). However, restraining factors such as fluctuation in anticoagulant medication level and stringent approval process are expected to hinder the market growth.

Geographically, North America is the largest market region for global cardiovascular prosthetic device market in terms of market revenue share. The key factors driving the market growth in North America is the rising prevalence of cardiovascular diseases in the U.S. Moreover, according to Silverbook, every year, approximately 5 million people in North America are diagnosed with heart valve disorders. Furthermore, increasing adoption rate of cardiovascular prosthetic devices along with rising geriatric population and the unhealthy lifestyle of the young generation is expected to propel the growth of market. However, Asia Pacific is expected to emerge as the fastest growing market region owing to the increasing geriatric population. As per the Help age organization, 3.8% of the population in India is found to be above the age of 90.

The global cardiovascular prosthetic devices market is influenced by the presence of leading companies such as Abbott laboratories , Biosensors International , Colibri Heart Valve, Inspiremd, Medtronic PLC. Product launch, joint venture, merger and acquisition are some of the crucial strategies adopted by the key market players to gain competitive advantage. 

Global cardiovascular prosthetic device market report covers segmentation analysis of type, applications and end users. Report further covers segments of types of cardiovascular prosthetic devices which include Cardiac Prosthetic Devices and Vascular Prosthetic Devices. Cardiac prosthetic devices such as stents and prosthetic heart valves are used to maintain the proper functionality of the heart. Stents are used to maintain the blood flow, and also helps in the reduction of blockage in the arteries, whereas prosthetic heart valves are being extensively adopted by patient suffering from heart valvular disease or dysfunctional heart valve. Cardiac prosthetic devices are the leading type segment owing to its increased adoption due to rising cardiac disorders. According to American Heart Association, the number of deaths due to cardiac disorder increased from 12.3 million in 1993 to 17.3 million in 2013 which further increased to 17.9 million in 2015. Cardiac prosthetic devices can be further categorised into prosthetic heart valves, annuloplasty rings, defibrillator leads, pacemaker leads, tissue patches, artificial hearts and ventricular assist devices. The end users of global cardiovascular prosthetic devices include Hospitals, Specialty Clinics and Ambulatory Surgical Centers (ASCS).



Note:
Please allow up to 72 hours for delivery.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Elixir Medical (U.S.)
  • Inspiremd (Israel)
  • Medtronic Plc. (U.S.)
  • Sorin Group (Italy)
  • Symetis Sa, (Switzerland)
  • MORE

1. Introduction
1.1. Executive Summary
1.2. Estimation Methodology
 
2. Market Overview
2.1. Global  Cardiovascular Prosthetic Devices  Market : Evolution & Transition
2.2. Market Definition & Scope
2.3. Industry Structure
2.4. Regulatory Framework
2.5. Total Market Analysis
2.5.1. Top 5 Findings
2.5.2. Top 5 Opportunity Markets
2.5.3. Top 5 Companies
2.5.4. Top 3 Competitive Strategies
2.6. Estimation Analysis
2.7. Strategic Analysis
2.7.1. Investment Vs. Adoption Model
2.7.2. 360-Degree Industry Analysis
2.7.3. Porters 5 Force Model
2.7.4. See-Saw Analysis
2.7.5. Consumer Analysis And Key Buying Criteria
2.8. Competitive Analysis
2.8.1. Key Strategies & Analysis
2.8.2. Market Share Analysis & Top Company Analysis
2.9. Strategic Recommendations & Key Conclusions
2.9.1. Investment Opportunities By Regions
2.9.2. Opportunities in Emerging Applications
2.9.3. Investment Opportunity in Fastest Growing Segment
 
3. Market Determinants
3.1. Market Drivers
3.1.1. Rising Prevalence of Cardiovascular Diseases
3.1.2.   Increasing Geriatric Population Base
3.1.3. Rising Health Insurance Coverage
3.1.4. Rising Preference for Minimally-Invasive Procedures
3.1.5. Increasing Prevalence of Valvular Disease And Atrial Septal Defect (Asd)
3.2. Market Restraints
3.2.1. Fluctuation in Anticoagulant Medication Level
3.2.2. Stringent Approval Process
3.3. Market Opportunities
3.3.1. Introduction of Technologically Advanced Products
3.3.2. Big Opportunities in Emerging Economies With High Unmet Needs
3.4.   Market Challenges
3.4.1. High Cost of Cardiovascular Prosthetic Devices 
3.4.2. High Requirement of Repetitive Surgeries
 
4. Market Segmentation
4.1. Global Cardiovascular Prosthetic Devices Market By Type
4.1.1. Market Definition And Scope
4.1.2. Decision Support Database & Estimation Methodology
4.1.3. Comparative Analysis Across Market Segments
4.1.4.  Opportunity Matrix
4.1.5. Market Segmentation
4.1.5.1. Global   Cardiac Prosthetic Devices Market
4.1.5.1.1. Adoption Scenario & Market Determinants
4.1.5.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.1.3. Key Players & Key Products
4.1.5.1.4. Key Conclusions
4.1.5.2. Global    Vascular Prosthetic Devices Market
4.1.5.2.1. Adoption Scenario & Market Determinants
4.1.5.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.2.3. Key Players & Key Products
4.1.5.2.4. Key Conclusions
4.2. Global Cardiovascular Prosthetic Devices Market By End User
4.2.1. Market Definition And Scope
4.2.2. Decision Support Database & Estimation Methodology
4.2.3. Comparative Analysis Across Market Segments
4.2.4.  Opportunity Matrix
4.2.5. Market Segmentation
4.2.5.1. Global    Hospitals Market
4.2.5.1.1. Adoption Scenario & Market Determinants
4.2.5.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.1.3. Key Players & Key Products
4.2.5.1.4. Key Conclusions
4.2.5.2. Global  Specialty Clinics Market
4.2.5.2.1. Adoption Scenario & Market Determinants
4.2.5.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.2.3. Key Players & Key Products
4.2.5.2.4. Key Conclusions
4.2.5.3. Global    Ambulatory Surgical Centers (Ascs) Market
4.2.5.3.1. Adoption Scenario & Market Determinants
4.2.5.3.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.3.3. Key Players & Key Products
4.2.5.3.4. Key Conclusions
 
5. Competitive Landscape
5.1. Key Strategies
5.1.1. List of Mergers And Acquisition
5.1.2. List of Joint Ventures
5.1.3. List of Product Launches
5.1.4. List of Partnerships
 
6. Geographic Analysis
6.1. Decision Support Database & Estimation Methodology
6.2. Comparative Analysis Across Market Segments
6.3. Opportunity Matrix
6.4.  Global Cardiovascular Prosthetic Devices Market By Region 2014-2023 ($ Million)
6.4.1. North America
6.4.1.1. Industry Analysis 2014-2023 ($ Million)
6.4.1.2. Top Country Analysis
6.4.1.2.1. U.S.
6.4.1.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.1.2.1.2. Key Players & Key Products
6.4.1.2.1.3. Key Conclusions
6.4.1.2.2. Canada
6.4.1.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.1.2.2.2. Key Players & Key Products
6.4.1.2.2.3. Key Conclusions
6.4.2. Europe
6.4.2.1. Industry Analysis 2014-2023 ($ Million)
6.4.2.2. Top Country Analysis
6.4.2.2.1. Uk
6.4.2.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.1.2. Key Players & Key Products
6.4.2.2.1.3. Key Conclusions
6.4.2.2.2. France
6.4.2.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.2.2. Key Players & Key Products
6.4.2.2.2.3. Key Conclusions
6.4.2.2.3. Germany
6.4.2.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.3.2. Key Players & Key Products
6.4.2.2.3.3. Key Conclusions
6.4.2.2.4. Spain
6.4.2.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.4.2. Key Players & Key Products
6.4.2.2.4.3. Key Conclusions
6.4.2.2.5. Rest of Europe
6.4.2.2.5.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.5.2. Key  Players & Key Products
6.4.2.2.5.3. Key Conclusions
6.4.3. Asia Pacific
6.4.3.1. Industry Analysis 2014-2023 ($ Million)
6.4.3.2. Top Country Analysis
6.4.3.2.1. China
6.4.3.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.1.2. Key Players & Key Products
6.4.3.2.1.3. Key Conclusions
6.4.3.2.2. India
6.4.3.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.2.2. Key Players & Key Products
6.4.3.2.2.3. Key Conclusions
6.4.3.2.3. Japan
6.4.3.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.3.2. Key Players & Key Products
6.4.3.2.3.3. Key Conclusions
6.4.3.2.4. Australia
6.4.3.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.4.2. Key  Players & Key Products
6.4.3.2.4.3. Key Conclusions
6.4.3.2.5. Rest of Asia Pacific
6.4.3.2.5.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.5.2. Key  Players & Key Products
6.4.3.2.5.3. Key Conclusions
6.4.4. Row
6.4.4.1. Industry Analysis 2014-2023 ($ Million)
6.4.4.2. Top Country Analysis
6.4.4.2.1. Latin America
6.4.4.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.1.2. Key Players & Key Products
6.4.4.2.1.3. Key Conclusions
6.4.4.2.2. Middle East & Africa
6.4.4.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.2.2. Key Players & Key Products
6.4.4.2.2.3. Key Conclusions
 
7. Company Profiles
7.1. Abbott Laboratories (U.S.)
7.1.1. Overview
7.1.2. Product Portfolio
7.1.3. Strategic Initiatives
7.1.4. Scot Analysis
7.1.5. Strategic Analysis
7.2. B. Braun Melsungen Ag, (Germany)
7.2.1. Overview
7.2.2. Product Portfolio
7.2.3. Strategic Initiatives
7.2.4. Scot Analysis
7.2.5. Strategic Analysis
7.3. Biosensors International (Singapore)
7.3.1. Overview
7.3.2. Product Portfolio
7.3.3. Strategic Initiatives
7.3.4. Scot Analysis
7.3.5. Strategic Analysis
7.4. Colibri Heart Valve (U.S.)
7.4.1. Overview
7.4.2. Product Portfolio
7.4.3. Strategic Initiatives
7.4.4. Scot Analysis
7.4.5. Strategic Analysis
7.5. Edwards Lifesciences Corp. (U.S.)
7.5.1. Overview
7.5.2. Product Portfolio
7.5.3. Strategic Initiatives
7.5.4. Scot Analysis
7.5.5. Strategic Analysis
7.6. Elixir Medical (U.S.)
7.6.1. Overview
7.6.2. Product Portfolio
7.6.3. Strategic Initiatives
7.6.4. Scot Analysis
7.6.5. Strategic Analysis
7.7. Inspiremd (Israel)
7.7.1. Overview
7.7.2. Product Portfolio
7.7.3. Strategic Initiatives
7.7.4. Scot Analysis
7.7.5. Strategic Analysis
7.8. Lifetech Scientific (Shenzhen) Co., Ltd. (China)
7.8.1. Overview
7.8.2. Product Portfolio
7.8.3. Strategic Initiatives
7.8.4. Scot Analysis
7.8.5. Strategic Analysis
7.9. Medtronic Plc. (U.S.)
7.9.1. Overview
7.9.2. Product Portfolio
7.9.3. Strategic Initiatives
7.9.4. Scot Analysis
7.9.5. Strategic Analysis
7.10. Meril Life Sciences Pvt. Ltd (India)
7.10.1. Overview
7.10.2. Product Portfolio
7.10.3. Strategic Initiatives
7.10.4. Scot Analysis
7.10.5. Strategic Analysis
7.11. Sorin Group (Italy)
7.11.1. Overview
7.11.2. Product Portfolio
7.11.3. Strategic Initiatives
7.11.4. Scot Analysis
7.11.5. Strategic Analysis
7.12.   Symetis Sa, (Switzerland)
7.12.1. Overview
7.12.2. Product Portfolio
7.12.3. Strategic Initiatives
7.12.4. Scot Analysis
7.12.5. Strategic Analysis
7.13. St. Jude Medical, Inc. (U.S.)
7.13.1. Overview
7.13.2. Product Portfolio
7.13.3. Strategic Initiatives
7.13.4. Scot Analysis
7.13.5. Strategic Analysis
7.14. Svelte Medical Systems (U.S.)
7.14.1. Overview
7.14.2. Product Portfolio
7.14.3. Strategic Initiatives
7.14.4. Scot Analysis
7.14.5. Strategic Analysis
7.15. W. L. Gore & Associates, Inc. (U.S.)
7.15.1. Overview
7.15.2. Product Portfolio
7.15.3. Strategic Initiatives
7.15.4. Scot Analysis
7.15.5. Strategic Analysis
 
List of Tables
1. Global Cardiovascular Prosthetic Devices Market By Type 2014-2023 ($ Million)
2. Global Cardiac Prosthetic Devices Market By Geography 2014-2023 ($ Million)
3. Global Vascular Prosthetic Devices Market By Geography 2014-2023 ($ Million)
4. Global Cardiovascular Prosthetic Devices Market By End Users 2014-2023 ($ Million)
5. Global Hospitals Market  By Geography 2014-2023 ($ Million)
6. Global  Specialty Clinics Market  By Geography 2014-2023 ($ Million)
7. Global Ambulatory Surgical Centers (Ascs)  Market  By Geography 2014-2023 ($ Million)
8. North America Cardiovascular Prosthetic Devices Market 2014-2023 ($ Million)
9. Europe Cardiovascular Prosthetic Devices  Market 2014-2023 ($ Million)
10. Asia Pacific Cardiovascular Prosthetic Devices Market 2014-2023 ($ Million)
11. Rest of the World Cardiovascular Prosthetic Devices Market 2014-2023 ($ Million)
 
List of Figures
1. Global Cardiac Prosthetic Devices Market 2014-2023 ($ Million)
2. Global Vascular Prosthetic Devices Market 2014-2023 ($ Million)
3. Global Hospitals Market   2014-2023 ($ Million)
4. Global  Specialty Clinics Market   2014-2023 ($ Million)
5. Global Ambulatory Surgical Centers (Ascs)  Market   2014-2023 ($ Million)
6. United States (U.S.) Cardiovascular Prosthetic Devices  Market 2014-2023 ($ Million)
7. Canada Cardiovascular Prosthetic Devices  Market 2014-2023 ($ Million)
8. United Kingdom (Uk) Cardiovascular Prosthetic Devices Market 2014-2023 ($ Million)
9. France Cardiovascular Prosthetic Devices  Market 2014-2023 ($ Million)
10. Germany Cardiovascular Prosthetic Devices Market 2014-2023 ($ Million)
11. Spain Cardiovascular Prosthetic Devices Market 2014-2023 ($ Million)
12. Roe Cardiovascular Prosthetic Devices Market 2014-2023 ($ Million)
13. India Cardiovascular Prosthetic Devices Market 2014-2023 ($ Million)
14. China Cardiovascular Prosthetic Devices Market 2014-2023 ($ Million)
15. Japan Cardiovascular Prosthetic Devices Market 2014-2023 ($ Million)
16. Australia Cardiovascular Prosthetic Devices Market 2014-2023 ($ Million)
17. Roapac Cardiovascular Prosthetic Devices Market 2014-2023 ($ Million)
18. Latin America Cardiovascular Prosthetic Devices Market 2014-2023 ($ Million)
19. Mena Cardiovascular Prosthetic Devices Market 2014-2023 ($ Million)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories (U.S.)
  • B. Braun Melsungen Ag, (Germany)
  • Biosensors International (Singapore)
  • Colibri Heart Valve (U.S.)
  • Edwards Lifesciences Corp. (U.S.)
  • Elixir Medical (U.S.)
  • Inspiremd (Israel)
  • Lifetech Scientific (Shenzhen) Co., Ltd. (China)
  • Medtronic Plc. (U.S.)
  • Meril Life Sciences Pvt. Ltd (India)
  • Sorin Group (Italy)
  • St. Jude Medical, Inc. (U.S.)
  • Svelte Medical Systems (U.S.)
  • Symetis Sa, (Switzerland)
  • W. L. Gore & Associates, Inc. (U.S.)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll